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Chlamydia has become the most prevalent sexually transmitted 
disease in the United States. Most infected women are 
asymptomatic carriers of the infection. Chlamydia is not a 
reportable disease in the State of Mississippi. Therefore, 
no data are available regarding the magnitude of infection 
in Northeast Mississippi. The purpose of this study was to 
identify asymptomatic chlamydial infections in pregnant 
women attending a midwifery clinic in Northeast Mississippi. 
The Neuman Systems Model identifying levels of prevention 
was utilized as the theoretical framework. The research 
questions guiding the study were what percentage of pregnant 
women are asymptomatic and what are the clinical, 
behavioral, and demographic characteristics of these women?
A descriptive correlational study was conducted at a 
midwifery clinic in Northeast Mississippi from March 1992 to 
September 1992. Subjects were 97 pregnant women. Chart 
review was utilized to identify clients with positive tests 
for chlamydia. The McAlpin Record of Demographic and 
Clinical Characteristics of Chlamydial Infection was 
utilized to identify demographic, behavioral, and clinical 
characteristics. Descriptive statistics were used to 
describe the sample. The chi-square (%̂ ) value of 48.984,
iv
df = 4, 2 = 0.000 revealed that the presence or absence of 
clinical characteristics were not predictive of test 
results. Correlational statistics, Pearson r = 0.1178, p =
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Chlamydia trachomatous has become the number one 
sexually transmitted disease in the United States and is 
soaring past gonorrhea by at least 2 to 1 (Center for 
Disease Control [CDC], 1989; Mansfield et al., 1986; 
Washington, Johnson & Sanders, 1987; Washington & Siegel, 
1987; Woolard, Larson, & Hudson, 1989). Washington and 
Siegel (1987) estimated that there were approximately 4 to 6 
million chlamydial infections annually in the United States.
Chlamydia trachomatous is not a reportable disease in 
the State of Mississippi. Therefore, no data exist for the 
prevalence of chlamydia in Northeast Mississippi.
Significant morbidity is associated with this 
infection. Chlamydial infections are associated with 50% of 
all nongonococcal urethritis (NGU) cases and 50% of acute 
epididymitis in men (Washington & Siegel, 1987), ectopic 
pregnancy, and tubular infertility (Mansfield et al., 1987; 
Nettleman et al., 1986).
Unfortunately, until recently chlamydia has been 
difficult to diagnose due to the expense of cell cultures 
and the difficulty in isolating the organism. There are now 
several direct antigen tests commercially available (Barnes,
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1989). Despite this fact and the recommendations by the CDC 
(1989) that routine screening be performed, this has not 
been the case. Instead only high-risk clients are being 
screened, the argument being that routine screening is not 
cost effective. However, many infected women are 
asymptomatic carriers and are at risk for significant 
sequelae if untreated.
How adversely the infection affects pregnancy and 
causes perinatal complications is controversial. Several 
studies show an association with chlamydial infections and 
premature rupture of membranes due to chorioamnionitis, 
premature labor, and late postpartum endometritis (Martin 
et al., 1982; Wager et al., 1980; Watts, Eschenbach, &
Kenny, 1989).
Perinatal transmission and the subsequent sequelae to 
the infant are well recognized (Schachter et al., 1986;
Sweet, Landers, Walker, & Schachter, 1987). In the infant, 
chlamydia is the most common cause of neonatal eye 
infections and pneumonia (Washington & Siegel, 1987).
Studies by Sweet et al. (1987) and Black-Payne, Ahrabi, 
Bocchini, Ridenour, and Brouillette (1990) showed that third 
trimester treatment with erythromycin interrupted the 
vertical transmission to the infant.
Washington et al. (1987) estimated that the annual cost 
for the sequelae of chlamydial infection is approximately $2 
million. Nettlemen and Bell (1991) investigated cost-
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effectiveness strategies for screening pregnant women for 
Chlamydia trachomatous. Screening could be cost effective 
if certain conditions were met. Direct antigen testing 
(versus cell cultures) of all pregnant women would be cost- 
effective if the test costs less than $6.50 or the 
prevalence of infection exceeded 6%. If cell cultures are 
used, the prevalence of infection must exceed 14.8%.
The dilemma for the health care provider revolves 
around the questions of when to screen pregnant women for 
chlamydia, especially if they do not have a clearly defined 
clinical syndrome or are asymptomatic. To deny screening 
because selective risk factors have not been identified 
places the pregnant woman and her infant at risk for 
chlamydial infections. Thus, the purpose of this study was 
to identify pregnant women with asymptomatic chlamydial 
infections.
Significance to Nursing
Activities directed toward health maintenance and 
disease prevention are appropriate actions for nurses in 
advanced practice. Assessment of the pregnant client for 
risk factors (STDS) through history taking and the 
application of screening procedures (STD testing) are 
examples of this activity.
Since no data exist is Mississippi regarding the 
prevalence of chlamydial infection, the magnitude of risk is 
unknown. This study determined the prevalence of infection
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within the sample. Will it be discovered that the 
prevalence is comparable to other samples? Will a 
significant percentage of these women be asymptomatic? If 
so, then the clinical decision to provide screening for 
pregnant clients will be simplified, even if they do not 
have a clearly defined clinical syndrome or are 
asymptomatic.
A thorough history and observation of clinical signs 
and symptoms are a necessity. However, clinical 
observations may not provide sufficient evidence to warrant 
screening based on selective criteria. Caution is warranted 
if selective screening is practiced. To deny screening 
because selected risk factors have not been identified 
places the pregnant woman and her infant at risk for 
chlamydial infections and potential consequences.
Nurse practitioners have a responsibility to educate 
women about the high incidence of chlamydial infection and 
the effects of undetected and untreated infection.
Education should encompass the mode of transmission, risk 
factors, symptoms, preventative measures, and the 
consequences to fertility, pregnancy outcome, and the 
infant.
As nurses in extended practice, we have a 
responsibility to keep abreast of the latest information 
regarding chlamydia and to inform other health-care 
providers of the high incidence rates and risks to infected
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individuals who go undetected and untreated. Information 
regarding the prevalence of chlamydial infections needs to 
be shared with local health-care agencies in an attempt to 
obtain funding and support for further testing and 
treatment.
Theoretical Framework
The theoretical framework guiding this study was based 
on levels of prevention as outlined by Neuman (Cross, 1990). 
Neuman's framework is an open systems model with the major 
components of stressors (presence of organisms), reaction to 
stressors (presence or absence of symptomatology), and the 
person interacting with the environment (the pregnant 
woman). Neuman's person is represented by a series of 
concentric circles with several flexible lines of defense 
around a central energy core. The pregnant woman's lines of 
defense are characterized by her behavioral and 
immunological lines of defense. Use of this organizing 
framework allows the nurse to intervene appropriately with 
health promotion (primary prevention, corrective [secondary 
prevention] or rehabilitative [tertiary prevention] nursing 
actions to maintain or restore equilibrium to the system 
[person]).
The fetus may be a stressor to the mother (i.e., PIH) 
or the mother may be a stressor to the fetus (i.e., 
infection). Perinatal nurses (family nurse practitioners) 
are in an ideal position to screen and identify existing and
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potential problems that may place the pregnant woman and her 
fetus at risk. Because the maternal-fetal unit impact on 
each other, a source of stressors, on the interpersonal 
level, is the transmission of infections (between persons). 
The effect of the stressor on the unit depends on the stage 
of pregnancy. The normal line of defense of the pregnant 
woman are threatened by infection (chlamydia) and can 
ultimately affect the fetal core (preterm labor) or threaten 
the delivered infant's lines of resistance (pneumonia. 
Ophthalmia Neonatorum) (Dunn & Trepanier, 1989).
To determine the priority for intervention, nurses must 
examine the degree that the stressor (chlamydial infection) 
penetrates the lines of defense. On the primary level, 
prevention of sexually transmitted diseases would involve 
teaching clients safe sex practices. The secondary level of 
prevention addresses assessment of the presence or absence 
of disease (stressors). This is accomplished by observation 
of clinical signs, client characteristics (those at risk), 
and application of appropriate screening tests.
Primary prevention can begin at any point at which a 
stressor is either suspected or identified. If a reaction 
has not occurred, the intervention would be at the primary 
level. The goal of primary prevention is to prevent the 
stressor, in this instance, the chlamydia organism, from 
penetrating the normal line of defense. One such
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appropriate activity would be the teaching of safe sex 
practices.
If primary prevention is not possible and reaction has 
occurred, intervention would begin at the level of secondary 
prevention. Secondary prevention deals mainly with early 
case finding, early treatment of symptoms, and attempts to 
strengthen the internal lines of resistance to reduce 
reaction (Cross, 1990). Sexually transmitted disease (STD) 
screening and identification of a disease process are 
secondary prevention activities. Treatment of asymptomatic 
carriers reduces reaction. Use of this model is appropriate 
to this study, that is, to determine not only the prevalence 
of chlamydia (the stressor) but to describe characteristics 
of the pregnant woman's level of defense.
Assumptions
The following assumptions are identified for this 
study:
1. Chlamydia trachomatous is the number one sexually 
transmitted disease in the United States.
2. Chlamydia has an extended incubation period.
3. Many women are asymptomatic carriers of the 
infection.
4. Secondary prevention activities are appropriate 
intervention for the nurse practitioner.
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Statement of the Problem/Purpose
This researcher observed a higher incidence of 
chlamydia over gonorrhea in the clinical setting. No data 
are available for the prevalence of chlamydia in pregnant 
women in northeast Mississippi. This researcher proposes to 
show through data collection and analysis that there is 
significant prevalence of chlamydia in pregnant women and 
that routine screening is necessary to identify and 
subsequently treat infected women to prevent the sequelae of 
undiagnosed infections. Therefore, the purpose of this 
study was to determine the prevalence of asymptomatic 
chlamydia in pregnancy.
Research Questions
The following research questions were formulated for 
this study:
1. What are the clinical characteristics of pregnant 
women with chlamydial infection?
2. What percentage of pregnant women presenting for 
examination are asymptomatic carriers of chlamydial 
infections?
3. Is there a relationship between common demographic 
and behavioral characteristics of pregnant women 
asymptomatic carriers of chlamydial infections?
Definition of Terms
For the purpose of this study, the following terms are 
defined :
Pregnant women; Those women seen on the initial visit, 
regardless of gestational age. Women presenting for initial 
examination, but previously identified by the health 
department as positive but untreated, will be excluded.
They do not represent new cases. Women who have completed a 
course of erythromycin or tetracycline, or its derivatives, 
in the preceding 6 weeks also will be excluded.
Chlamydial infection; Chlamydia trachomatous, an 
obligate intracellular organism, which is sexually 
transmitted and identified by use of GenProbe, a nucleic 
acid probe, sent to a reference laboratory. GenProbe is a 
antigen detection method.
Asymptomatic carriers : Clients with positive tests but
no identifiable symptoms.
Clinical characteristics; Presence of any of the 
following, with or without a positive test; friable 
(bleeding) cervix, mucopurulent discharge, and white blood 
counts greater than 10 per high power field (phf) on a wet 
mount.
Demographic characteristics ; Age, race, marital 
status, Medicaid recipients, educational level, parity, and 
gestational age.
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Behavioral characteristics; The number of sexual 
partners in the preceding year.
Chapter II 
Review of the Literature
In preparation for this investigation, several studies 
regarding prevalence, risk factors, and sequela of 
chlamydial infections were reviewed in both nonpregnant and 
pregnant women. Of the studies reviewed, prevalence of 
chlamydial infections varied from 8.1% to 12.4% in 
nonpregnant women (Addiss, Vaughn, Holzhurter, Bakken, & 
Deaves, 1985; Linder, Geerling, Nettum, Miller, & Altman, 
1988; Mansfield et al., 1986; Swinker, Young, Cleavenger, 
Neely, & Palmer, 1988; Trachtenberg, Washington, & 
Holldorson, 1988; Woolard et al., 1989). In pregnancy the 
rates vary from 4.7% to 26% (Abel & von Unwerth, 1988; 
Bagshaw & Edwards, 1987; Black-Payne, 1990; Martin et al., 
1982; Sweet et al., 1987). The prevalence of gonorrhea in 
the same studies were 2% or less (Abel & von Unwerth, 1988; 
Addiss et al., 1985; Swinker et al., 1988; Woolard et al., 
1989). Washington and Siegel (1987) estimated that 50% to 
70% of the women infected with chlamydia are asymptomatic. 
The women may remain asymptomatic for extended periods of 
time (CDC, 1989).
Several prospective studies showed an association with 
severe pregnancy complication for untreated chlamydial
11
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infections. Women infected with chlamydia had a higher 
incidence of late postpartum endometritis (> 48 hours to 6 
weeks) (Watts et al., 1989), premature rupture of membranes, 
preterm labor, and chorioamnionitis (Martin et al., 1982; 
Wager et al., 1980).
Other studies have been conducted to establish 
selective criteria for screening only high-risk clients. 
(Addiss et al., 1985; Mansfield et al., 1986). Conversely, 
studies by Abel & von Unwerth (1988), Bagshaw & Edwards 
(1987), Linder et al. (1988), and Swinker et al. (1988) 
showed that there was no single symptom or characteristic 
that was predictive of infection. In fact, most women in 
these samples were asymptomatic.
The CDC (1989) has recommended routine screening for 
detection of chlamydial infections, and most researchers 
concluded that this is desirable. Merein lies the 
controversy. Chlamydia trachomatous is an obligate 
intracellular parasite and can only be cultivated in tissue 
cultures, which are costly and difficult to preserve and 
transport adequately in a clinic setting. Mowever, recent 
clinical advances have yielded direct antigen tests. Thus, 
the identification of chlamydia is simplified with a 
reduction in cost.
Mansfield et al.'s (1986) descriptive study of 1,059 
nonpregnant women attending two urban family planning 
clinics sought to develop a criteria for selective screening 
of clients with chlamydial infections. Clients were
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interviewed for a routine medical history, which included 
questions regarding contraceptive methods, genitourinary 
symptoms, and sexual history. A gynecological examination 
was performed.
Five demographic, behavioral and clinical 
characteristics (diagnostic indicators) were independently 
predictive of chlamydial infection by stepwise multivariate 
logistic regression analysis. The characteristics were 
mucopurulent cervical discharge, a friable cervix, a new 
sexual partner within the preceding 2 months, younger than 
24 years of age, and use of no contraceptive or a non­
barrier method. The prevalence of chlamydia for this sample 
was 9.3%.
Hansfield et al.'s (1986) study does recommend routine 
screening for chlamydia along with gonorrhea testing, as 
recommended by the CDC. The study suggests the use of 
selective criteria for screening where resources are 
limited. It claims that the use of selective criteria will 
identify 90% of those women infected with chlamydia; 
however, that leaves 10% of infected cases undetected and 
untreated.
Hansfield et al.'s study is important because it 
established selective screening criteria followed by many 
clinics. It also became the key reference in other studies 
attempting to identify risk factors.
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An opposing view to Hansfield et al. (1986) in regard 
to diagnostic indicators associated with chlamydia was 
presented by Woolard et al. (1989). The purpose of this 
descriptive study was to determine the prevalence of 
chlamydial infections in college family planning patients 
and to identify diagnostic indicators associated with 
chlamydia. A convenience sample of 419 female clients 
presenting to a small midwestern university health service 
was obtained. Routine history and physical examinations 
were performed on all subjects. The author used chi-square, 
t test, and Fisher's exact probability test (one-tail) to 
determine the statistical relationship between infected and 
noninfected clients.
The prevalence was 12.6% (n = 53) for this sample. The 
clinical signs of infection, including mucopurulent cervical 
discharge and cervicitis, did not occur as diagnostic 
indicators in this sample. Of the clients who tested 
positive for chlamydia, 74% lacked the clinical signs of 
mucopurulent discharge or cervicitis. Six subjects 
complained of symptoms of a vaginal infection but tested 
negative.
Woolard et al. (1989) concluded that the importance was 
finding neither the presence nor the absence of signs and 
symptoms as significant diagnostic indicators. The results 
revealed that the number of sex partners or a new partner 
was significantly related to the incidence of infection.
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The limitations of this study include inaccuracy in 
historical data reported by the clients for symptoms, sexual 
history, and recent use of antibiotics. The sample was 
homogenous, primarily white, middle-class clients. Risk 
factors associated with race and economic levels were not 
addressed.
The importance of this study is that it suggests that 
there is a significant reservoir of women who are 
asymptomatic. This information raises the question of the 
advisability of selective screening.
The studies demonstrated a significant incidence of 
chlamydia and suggested that many women are asymptomatic. 
Many of these women are not identified for screening during 
their annual family planning visits. It would be a 
reasonable assumption that these women were already infected 
when they presented for prenatal care. Alternately, they 
may never have presented for family planning and became 
infected and pregnant in a brief period of time.
The incidence of gonorrhea and chlamydia in pregnant 
women was compared by Abel and von Unwerth (1988). The 
hypothesis was that the incidence of chlamydia would exceed 
the incidence of gonorrhea among pregnant women at 34 weeks 
or more gestation. The nonexperimental design utilized a 
convenience cluster sample of 117 women who were selected 
from five antepartum clinics in three counties (one urban 
and two rural) in a southern state.
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Nonparametric statistics (chi-square) were used to 
examine statistical difference between positive or negative 
test results and selected demographic, behavioral and 
clinical characteristics. Abel and von Unwerth stated in 
the results that the hypothesis was supported. The 
incidence of chlamydia for this population was 22.5% (n = 
25), and the incidence of gonorrhea was 1.8%. Demographic 
and behavioral variables were identified, including age, 
race, marital status, income, and the number of sex partners 
during the past year. Clinical variables identified were 
ectopic or friable cervix, mucopurulent discharge, and 
evidence of other STDs.
Contrary to the Hansfield et al. study, none of the 
diagnostic indicators were found to be significantly 
associated with chlamydia. Had the diagnostic indicators 
been used for selective screening 76% (n = 19) of the women 
who tested positive, would not have been screened.
The limitations of this study are related to the 
sampling techniques, a convenience sample (the weakest form 
of sampling), the small size (N = 117), and the small sub­
sample of subjects with positive test results (n = 25). The 
sample size of 117 women is probability adequate to make 
some assumptions about the results. However, other studies 
have utilized hundreds, even thousands of women, which lend 
more power to the assumptions (as a general rule of thumb).
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The strengths of the study were that the incidence rate 
of chlamydia was consistent with other studies. The study 
demonstrated several asymptomatic women. These results are 
in contrast to a major study that recommended selective 
screening for symptomatic women. Abel and von Unwerth 
suggest that use of selective criteria for screening 
pregnant women for chlamydia places the woman and her infant 
at risk of infection and the associated sequelae of 
undiagnosed chlamydial infections.
Black-Payne et al. (1990) conducted a nonexperimental 
prospective study to determine if routine testing with 
direct antigen methods could be used reliably in a screening 
program to identify and thus treat chlamydial infections in 
pregnant women to prevent perinatal transmissions of the 
organism to their infants. It is not stated how the sample 
of 199 asymptomatic women were obtained. The women were 
identified as infected and treated appropriately. The 
researchers then followed up on the infants during the first 
6 to 8 weeks of life. Pregnancy outcome was determined by 
chart review.
Affected infants born to chlamydia positive mothers, 
were examined at various sites, and mothers were given a 
questionnaire regarding prenatal drug compliance, drug side 
effects, and medication compliance of their sexual partner.
A comparison group was established which consisted of 
infants born to 48 mothers who tested negative. They were
18
selected by systematic sampling technique for telephone 
accessibility. Questions were asked regarding the incidence 
of the sequela in question: conjunctivitis, otitis media, 
severity of upper respiratory infections, and/or pneumonia. 
The study identified primiparous, single, young, black women 
as being the group at highest risk for infection. Data 
showed that third trimester treatment of chlamydia infected 
women prevents transmission to the neonate and avoidance of 
illness in the infant.
The major strength of this study is that the data 
confirmed previous studies regarding chlamydia treatment in 
pregnancy. The major weakness of the study was its 
inability to identify potential postpartum complications, 
specifically, early versus late onset of endometritis of 
noncompliant clients.
The implication for practitioners is that screening is 
indeed critical. Effective treatment can not be initiated 
unless infected clients are identified. Secondly, effective 
treatment and compliance are essential to prevent neonatal 
infections. This statement seems obvious. However, there 
are articles in the literature that do not recommend routine 
screening because neonatal conjunctivitis and pneumonia are 
effectively treated by oral erythromycin.
Concern as to whether adverse pregnancy outcome is 
associated with chlamydial infections has been studied. In 
particular. Sweet et al. (19 87) conducted a prospective
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observational study of cervical and vaginal infections to 
determine the effects on pregnancy outcome.
All women enrolled at their initial prenatal visit were 
entered into the study, after informed consent had been 
obtained. Over a 27-month period, 6,864 women were screened 
with vaginal and cervical cultures, blood serum of IgM 
antibodies, and demographics data.
The 270 women with positive chlamydia test results were 
matched with 270 control subjects for age 1 year, race and 
socioeconomic status. Of the 6,864 women in the study, only 
3,293 women were also screened for gonorrhea, and vaginal 
cultures were obtained for group B strep, mycoplasma, and 
ureaplasma. These organisms have also been implicated in 
adverse pregnancy outcome.
This study used simple univariate analysis and matched 
pair testing to compare patients with positive chlamydia 
cultures with negative matched controls. They also utilized 
logistic regression to control for the covariables of group 
B strep, mycoplasma, and ureaplasma.
The results showed that among the entire group (N =
54 0 [270 cases, 270 controls]), the rates of pregnancy 
complications were as follows: 10% premature rupture of
membranes, 11% preterm labor, 4% amnionitis, 4.3% 
intrapartum fever, 14.5% small for gestational age, 10% 
postpartum endometritis, and 10% neonatal sepsis. No 
statistically significant differences were noted between
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cases and controls for any of these variables. In a subset 
of women with recent or invasive chlamydial infection 
(presence of IgM antibodies), preterm labor and premature 
rupture of membranes were higher when compared to the 
controls.
The strong point of this study comes from the 
prospective nature of the design. The researchers included 
other known pathogens that can adversely affect pregnancy 
outcome and used statistical control to separate out the 
potential impact of chlamydial infection.
Conversely, they were unable to demonstrate the true 
effect of group B strep on pregnancy, as had been 
demonstrated in other studies. The researchers obtained 
vaginal instead of cervical cultures for B strep, 
mycoplasma, and ureaplasma. This difference in culturing 
technique may account for their inability to show an 
association between B strep and adverse pregnancy outcome. 
Can it be concluded that it is chlamydia or B strep alone or 
in combination that affects pregnancy outcome adversely?
This study contributes to a growing body of knowledge 
regarding the controversial effects of chlamydial infection 
and pregnancy outcome.
Conclusion
Despite the fact that no data exist in Mississippi 
regarding the prevalence of Chlamydia trachomatous, the 
magnitude of this STD is well-documented nationally. Most
21
researchers recognize the need for routine screening as 
recommended by the CDC.
Chapter III 
The Method
No data are available for the prevalence of chlamydia 
in pregnant women in Northeast Mississippi. The purpose of 
this study was to determine the prevalence of asymptomatic 
chlamydia in pregnancy.
Design of the Study
To achieve the purpose of this study, a descriptive, 
correlational design was selected. The purpose of a 
descriptive study is to observe, describe, and document 
aspects of a situation as it naturally occurs (Polit & 
Hungler, 1991). This design allows the researcher to report 
the prevalence of chlamydial infection in the selected 
sample and determine selected demographic, clinical, and 
behavioral characteristics.
According to Polit and Hungler (1991), a correlational 
study is an interrelationship or association between two 
variables, that is, a tendency for variation in one variable 
to be related to variation in another. The researcher will 
describe and correlate the relationships between selected 
demographic, behavioral and clinical characteristics 
(variables), and test results.
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Limitations. The following limitations were identified 
for this study:
1. The sampling technique selected was that of a 
purposeful sample, which is a weak form of sampling.
2. The sample size was small (N = 97). The larger the 
sample size, the more powerful the assumptions; and the 
ability to generalize to other samples is restricted.
3. The use of only one clinical site produces a 
homogenous group.
Setting, Population, and Sample
The setting was a midwifery clinic in Northeast 
Mississippi. The sample was a purposive sample drawn from a 
population of 97 pregnant women presenting for initial 
examination who met the inclusion criteria.
Polit and Hungler (1991) state that a purposive 
sampling derives from the belief that a researcher's 
knowledge about the population and its elements can be used 
to handpick the cases to be included in the sample. This 
researcher purposely selected the widest possible variety of 
respondents--all pregnant women presenting for initial 
examination.
Protection of human rights. Prior to data collection, 
approval was obtained from the Committee on Use of Human 
Subjects in Experimentation of the Mississippi University 
for Women (see Appendix A). In addition, permission for
24
chart review was obtained from the appropriate hospital 
review board (see Appendix B).
Methods of Data Collection
Data collection methods. The clinical records were 
reviewed retrospectively each month. Utilizing clinical 
records, the researcher was able to identify pregnant 
clients with positive test results. Data were collected for 
a 6-month period or until 97 women were tested. The McAlpin 
Record of Demographic and Clinical Characteristics of 
Chlamydial infections was utilized to identify demographic, 
behavioral, and clinical characteristics (see Appendix C). 
The researcher developed this data collection tool, after 
noting the most frequently identified symptoms in the 
literature review. The most common demographics reviewed 
were age, race, parity, educational level, and multiple 
partners. The clinical characteristics most often 
identified were cervical friability, mucopurulent discharge, 
WBC > 10 phf, and concomitant STDs/vaginal infections.
Clinical procedure. The midwifery clinic is staffed by 
four certified nurse midwives, including the researcher.
This hospital-sponsored program offers antepartum, 
intrapartum, and gynecological care.
The routine procedure for assessing risk for sexually 
transmitted diseases at Midwifery Service includes a 
gynecological and sexual history, as part of the routine 
medical history. Screening tests for syphilis, gonorrhea.
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chlamydia, and vaginitis are obtained on all pregnant 
patients initially. Most clients receive repeat testing at 
approximately 36 weeks. The cost of these procedures is 
calculated into the cost for care. Thus, no extra cost is 
incurred by the clients for the purposes of this study.
A speculum examination was performed as part of the 
initial physical assessment by one of four certified nurse- 
midwives. A pap smear and a gonorrhea culture were obtained 
first, then excessive cervical mucus was wiped away, and a 
sample of cervical mucous was obtained for chlamydial 
testing according to manufacturer's directions.
Additionally, vaginal secretions were obtained for 
microscopic examination of WBCs > 10 phf, yeast, 
trichomonas, and bacterial vaginosis.
The direct antigen test utilized on each client was 
GenProbe. GenProbe is a nucleic acid probe (GenProbe,
1991). It has a reported sensitivity of 89-95% and is 
considered comparable to cell cultures and Chiamydiazyme, 
another widely used antigen test (Barnes, 1989).
Pilot study. A retrospective chart review was 
conducted by the researcher several months prior to the 
current study. The setting and sample were the same as the 
current study. Records were reviewed of all clients who had 
tested positive for chlamydia from April 16, 1991, to 
October 1, 1991.
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The demographic characteristics selected for review 
were age, parity, medicaid assistance, race, number of 
sexual partners, marital status, and educational level. 
Record review led to identification of documented absence or 
presence of symptoms and other concurrent sexually 
transmitted diseases. The data collection tool was the same 
as Part I of McAlpin Record of Demographic and Clinical 
Characteristics. Part II, Clinical Characteristics, was 
developed for the current study. The researcher realized 
that more extensive documentation was needed regarding 
symptomatology.
The records of 54 pregnant women screened for chlamydia 
were reviewed. There were 18 positive tests representing an 
incidence of 33%. The most common characteristics of the 
sample were single, young (under 20), black, primiparous 
women, who were socioeconomically disadvantaged. A third 
(33%) of the subsample were asymptomatic.
The prevalence of 33% was higher than the studies 
reviewed. The percentage of asymptomatic women was 
consistent with other studies. Although there were common 
characteristics for the infected sample, there was no single 
symptom or combination of symptoms that identified all 
cases.
The study was limited in the number screened (n = 54) 
and in the number of positive cases (n = 18). The scope of 
this study was limited because only positive cases were
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reviewed, and no attempt was made to compare the selected 
characteristics to pregnant clients testing negative.
Despite the limitations of this study, there were 
implications for further research. A replication of this 
study using a larger sample could serve to overcome the 
limitations of a small subsample, that is, positive cases.
A larger sample should also compare selected characteristics 
between positive and negative test groups. An expansion of 
demographic variables and clinical symptoms may or may not 
strengthen the supposition that there is no definitive 
syndrome to identify all cases.
Data Analysis
Data analysis utilized chi-square {%) to determine the 
observed and expected frequencies of chlamydial infection in 
the sample. The chi-square is a non-parametric test used 
when the researcher is interested in the number of responses 
that fall in two or more categories. Goodness of fit refers 
to whether a significant difference exists between an 
observed number and the expected number of responses (Hucks, 
Cormeir, & Bounds, 1974). Correlational statistics were 
used to discover the relationship between the demographic 
variables, symptomatology, and test results. The Pearson 
Product Moment Correlation denotes the nature and size of 
the relationship between two variables (Hucks et al., 1974).
Tabulation of the results were gathered from the 
McAlpin Record of Demographic and Clinical Characteristics.
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Frequency distribution tables were used to describe the 
demographic, behavioral, and clinical variables.
Chapter IV 
The Findings
The purpose of this study was to determine the 
prevalence of asymptomatic chlamydia in pregnancy. A 
descriptive, correlational design was selected to achieve 
this purpose.
Sample Profile
The goal was to select 100 pregnant women. However, 
data collection was terminated at 97 due to new CLIA 
(Clinical Laboratory Improvement Act) regulations. The list 
of waived procedures did not include wet preps for 
microscopic examination and thus cannot be performed outside 
a properly licensed laboratory.
The 97 subjects were pregnant women presenting for 
initial examination at varying lengths of gestation. The 
length of pregnancy ranged from 4 to 37 weeks gestation, 
with 64% presenting by the 20th week. Primigravidas 
represented 52% of the sample. African American women 
comprised 67% of the sample, followed by 29% Caucasian, and 
3% other ethnic or racial groups.
The age of clients ranged from 15 to 39 years, the mean 
age being 22 years. Seventy-one clients (73%) were between 
the ages of 18 and 25 years. Other demographic
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characteristics were as follows: 72% single, 44% completed
the 12th grade, and 85.5% received Medicaid or were Medicaid 
eligible. For the behavioral characteristic of number of 
sexual partners, data were not available for three subjects. 
Seventy percent (n = 66) admitted to only one sexual partner 
in the current year, while 22% (n = 21) admitted to two 
partners. The remaining 7 claimed more than two partners in 
a single year (see Table 1).
Descriptive Analysis
Ninety-seven clients were tested for Chlamydia 
trachomatous. Fifteen women (15.5%) tested positive for 
infection. Twenty-nine women demonstrated at least one 
clinical characteristic (symptom). Of these 29 subjects, 23 
tested negative for chlamydia. The most common clinical 
characteristic was a vaginitis, with yeast being the most 
frequent infective agent (see Figure 1). There were 5 
(5.15%) cases of gonorrhea.
Of the 15 positive cases with chlamydia, 60% (n = 9) 
were without the classical symptoms of friable cervix, 
mucopurulent discharge (as identified by Hansfield et al., 
1986) and WBC > 10 phf (see Figure 2). The clinical 
characteristics present in the other 6 cases were 
mucopurulent discharge (2) and WBC > 10 (4). A variety of 
vaginitis was identified. Additionally, 4 out of 5 cases of 
gonorrhea were also chlamydia positive. Coincidentally,
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only one subject had syphilis (1%). She tested negative for 
gonorrhea and chlamydia.
Table 1


















No. of sex partners
One 5 61
Multiple 9 19
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Figure 2. Clinical characteristics of subjects with 
chlamydia (n = 15).
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Twenty-nine subjects demonstrated at least one clinical 
characteristic, while 14 of this group had multiple 
symptoms, and they tested negative. The clinical 
characteristics noted were friable cervix (6), mucopurulent 
discharge (2), WBC >10 (10), and a variety of vaginitis (21) 
(see Figure 3).
Data on white blood cells (WBC) were not complete for 
all subjects due to technical difficulties or lack of 
documentation. Ultimately, data on WBCs were collected for 
34 out of 97 subjects. Forty-one percent (n = 14) of these 
cases demonstrated WBC > 10.
Correlational Studies
Chi-square procedures were used to examine statistical 
differences between positive and negative test results and 
presence of clinical characteristics. It was demonstrated 
that presence or absence of clinical characteristics were 
not predictive of test results. The chi-square value was 
48.984, = 4 , 2 =  0.000, thus the values skewed beyond the
5% level of significance. Test results for two cases were 
lost during data collection, thus when a statistical program 
was computated, more than four cells (nine cells) were 
established, some with frequencies less than 5. Therefore, 







































































S Y M P TO M S
Figure 3. Clinical characteristics of subjects with 
symptoms (n = 29).
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Correlation between test results and clinical 
characteristics was done using the Pearson Product Moment 
Correlation. The value for the Pearson r was 0.178, p = 
0.1571, and revealed no correlation between test results and 
clinical characteristics.
Summary
The clients infected with chlamydia were single, mostly 
African American, and medically indigent. The majority had 
more than one sexual partner in the preceding year. There 
was no correlation between clinical characteristics and test 
results. In fact, 60% of the infected cases were 
asymptomatic, and 23.7% of the entire sample demonstrated 
clinical characteristics with a negative test.
Chapter V 
The Outcomes
Chlamydia has become the most prevalent sexually 
transmitted disease in the United States. This disease 
outnumbers gonorrhea by at least 2 to 1. Most infected 
women are asymptomatic carriers of the infection. Chlamydia 
is not a reportable disease in the state of Mississippi. 
Therefore, no data are available regarding the magnitude of 
infection in Northeast Mississippi.
The purpose of this study was to identify asymptomatic 
chlamydial infections in pregnant women attending a 
midwifery clinic in Northeast Mississippi. The research 
questions guiding the study were what percentage of pregnant 
women are asymptomatic and what are the clinical, 
behavioral, and demographic characteristics of these women.
Summary of Findings
The prevalence of chlamydia for this sample was 15.5%
(n = 15), with 60% (n = 9) of these cases failing to exhibit 
all three classical clinical characteristics of a friable 
cervix, mucopurulent discharge, and WBC > 10 phf. Most 




The identified clinical characteristics for this sample 
of pregnant women with chlamydia were mucopurulent discharge 
and WBC > lO phf. As discussed in the findings, no positive 
cases presented with a friable cervix.
The demographic and behavioral characteristics of 
positive cases revealed that the women were all single, 
black (one exception), and 15 to 29 years of age, with the 
highest concentration of cases being in the 18 to 22 years 
age group. The infected clients were evenly divided 
regarding parity (8 primigravidas and 7 multigravidas).
Nine out of 15 infected women admitted to more than one 
sexual partner.
Discussion
Hansfield et al. (1986) recommended selected screening 
of clients if two or more of the predictive demographic, 
behavioral, and clinical characteristics were present 
(mucopurulent discharge, friable cervix, a new sexual 
partner within the preceding 2 months, younger than 24 years 
of age, and nonuse of contraceptives or nonbarrier method). 
Had this criterion been used, the researcher would have 
missed screening almost half the sample population.
Interestingly, several women (n = 23) demonstrated 
clinical characteristics, with negative test results. There 
were 6 incidents of a friable cervix, 2 of mucopurulent 
discharge, and 10 of WBC > 10. Vaginitis (single or mixed 
organisms) was the most common characteristic. Vaginitis
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alone is not indicative of chlamydia or gonorrhea, although 
some organisms tend to cluster together. These results are 
consistent with Woolard et al. (1989), who concluded that 
the presence or absence of signs or symptoms were not the 
most significant diagnostic indicators. Woolard et al. 
reported that the number of sexual partners or a new partner 
was significantly related to the incidence of infection. 
While 60% (n = 9) of the subjects in this study reported 
more than one partner, only 23% (n = 19) of the subjects 
without chlamydia (n = 82) reported two or more partners.
The incidence of gonorrhea for the sample was 5.15% (n 
= 5). Four of these clients coincidentally had chlamydia. 
This disparity between the incidence of the two infections 
is consistent with all the studies reviewed, thus supporting 
the data that chlamydia occurs by at least a 2 to 1 margin. 
Had the researcher screened only for gonorrhea and treated 
those five clients for gonorrhea and chlamydia as 
recommended by the CDC and other researchers, 11 cases would 
have gone undetected and untreated.
In comparing the current sample (n = 97) with the pilot 
study (n = 54) conducted by the researcher in the Fall of 
1991, it is noted that the incidence of chlamydia is 15% 
versus 33%. The incidence of gonorrhea for the pilot study 
was 16% (n = 3) versus the current 5.15% (n = 5). The 
selected demographics were slightly expanded. The 
difference between the two studies may be attributed to the
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characteristics of women testing positive and negative for 
chlamydia. The current study also sought to discover if 
women were asymptomatic, and if any clinical characteristics 
were present in women testing negative for infection. 
Positive cases in both samples were usually single, black, 
and medically indigent (Medicaid eligible) women. Subjects 
in the current study were older (3 > 24 years) and evenly 
divided between primigravida and multigravida women.
The consistent characteristics of this sample were 
race, marital status, and number of sexual partners. Over 
half of the positive cases lacked clinical characteristics 
that would lead to selective screening. Abel and von 
Unwerth (1988) demonstrated an incidence of chlamydia of 
22.5% (n = 25) in their sample of 119 pregnant women, with 
7 6% (n = 19) of the sample being asymptomatic. Abel and von 
Unwerth did not find any of the clinical syndrome 
characteristics to be significantly associated with 
chlamydia. The current study findings are consistent with 
results noted by Abel and von Unwerth (1988) and Woolard et 
al. (1989), all in contrast to Hansfield et al. (1986).
Utilizing the Neuman Systems Model, management of 
perinatal clients occurs at three different levels (primary, 
secondary, and tertiary) in a variety of settings (hospital, 
clinics, and community health agencies). The nursing 
process places emphasis on both assessment of the major 
stressors that jeopardize maternal, fetal, or neonatal
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welfare and on the primary, secondary, and tertiary 
intervention strategies that help the client attain and 
maintain wellness. Although Neuman's model allows for a 
holistic, total person approach for assessment, this study 
focused on a single area, i.e. application of a screening 
test for a sexually transmitted disease.
Because the goal of perinatal health is the reduction 
of maternal, fetal, and neonatal morbidity to the lowest 
attainable level, the identification of clients at risk is 
an essential component of comprehensive prenatal care. The 
study revealed a high incidence of chlamydial infection 
(15.5%), with more than half the cases being asymptomatic 
(60%). The results support the need for routine chlamydia 
screening during pregnancy, regardless of clinical 
characteristics.
The limitations of this study are related to sampling 
technique, a purposeful sample (a weak form of sampling). 
Polit and Hungler (1991) note that a purposive sampling 
derives from the belief that a researcher's knowledge about 
the population and its elements can be used to handpick the 
cases to be included in the sample. This researcher 
purposely selected the widest possible variety of 
respondents, i.e. all pregnant women presenting for initial 
examination. Polit and Hungler suggest a purposeful sample 
be avoided, especially if the group is homogenous.
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Another limitation could be the small sample size (n = 
97), the small subsample of positive cases (n = 15), and 
data collection of the clinical and behavioral 
characteristics. The current sample size was double the 
size of the pilot study (n = 54). However, the sample size 
of 97 women may be adequate to make some assumptions and 
note some trends about the results. Other studies have 
utilized hundreds of women, which lends more power to the 
assumptions.
Data were lost when the microscope was broken for 
several weeks. When data collection resumed, documentation 
of WBCs was not consistent. Data on WBCs were documented 
for 34 subjects. Additionally, historical inaccuracies may 
have existed for data regarding sexual history. Many women 
were embarrassed to admit to more than one sexual partner.
Finally, a number of subjects (n = 23) demonstrated 
clinical characteristics (symptoms) but tested negative for 
chlamydia. This could indicate that these characteristics 
are not exclusively diagnostic of chlamydia or the test may 
have been inaccurate. The reported sensitivity and 
specificity of GenProbe are good, and the test is considered 
an appropriate alternative to cell cultures. However, it is 
a screening test and there is margin for error.
As reported in Chapter IV, the chi-square (%̂ ) value 
was 48.984, with a probability of zero (p = 0.000). These 
statistics show that there is no relationship between test
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results and the presence or absence of clinical 
characteristics. The value for Pearson r = 0.17 also shows 
that there is no correlation between test results and 
clinical characteristics in this sample.
The findings of this study reveal that this sample 
population had a high incidence of chlamydia, in pregnancy, 
with 60% of the cases being asymptomatic. The incidence of 
chlamydia was almost four times higher than gonorrhea. The 
selected demographic, behavioral, and clinical 
characteristics (risk factors) were similar to those used in 
other studies presented in the literature. It was shown 
that the characteristics (symptoms) occurred in subjects 
testing negative (absence of infection). The only 
consistent characteristics were race and marital status. 
Other reported risk factors were not found to be 
significantly associated with chlamydia. Utilization of 
selective screening for this sample would have missed 
positive cases and exposed the pregnant women and their 
infants to the sequelae of undiagnosed infection.
Implications for Nursing
It was discovered that chlamydia in this sample of 
pregnant women is significant and comparable to that in the 
studies reviewed. A significant percentage (60%) of the 
sample was asymptomatic. Had the researcher limited 
screening to selected clients, all cases would not have been 
identified. Also, had screening for sexually transmitted
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diseases been limited to gonorrhea and followed up with 
blind treatment for chlamydia, the majority of women with a 
positive chlamydia test would not have been identified. 
Therefore, the clinical decision to screen pregnant women 
for chlamydial infection, even if they do not present with a 
clearly defined clinical syndrome, is crucial if nurse 
clinicians are to achieve the goal of good perinatal health.
As nurses in extended practice, we have a 
responsibility to keep abreast of the latest information 
regarding chlamydia and to inform other health care 
providers of the high incidence rate and risks to infected 
individuals who go undetected and untreated. Information 
regarding the prevalence of chlamydial infections needs to 
be shared with local health care agencies in an attempt to 
obtain funding and support for reporting, testing, treating, 
and tracking.
Nurse practitioners have a responsibility to educate 
women about the high incidence of chlamydial infections and 
the effects of undetected and untreated infection.
Education should encompass the mode of transmission, risk 
factors, symptoms, preventive measures, and the consequences 
to fertility, pregnancy outcome, and the infant.
Recommendations
These findings have implication for further research. 
Chlamydia is not a reportable disease in Mississippi and, 
therefore, not a priority for tracking untreated cases, as
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is done for syphilis and gonorrhea. Utilizing larger 
samples, with different populations, could serve to overcome 
the limitations of a small group, particularly homogeneity. 
Replication of this study at other sites throughout the 
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c/o Graduate Nursing ProgramCampus
Dear Ms. McAlpin:
I am pleased to inform you that the members of the Committee 
on Human Subjects in Experimentation have approved your proposed 
project, "Prevalence of Asymptomatic Chlamydia in Pregnancy."
I wish you much success in your research.
Sincerely,




cc; Mr. Jim Davidson 
Ms. Jeri England 
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Mr. Charlie Faulkner 
Administrator
Golden Triangle Regional Medical Center 
2520 5th Street North 
Columbus, MS 39701
Dear Mr. Faulkner;
I am requesting permission to utilize the clinical records 
of pregnant clients at Midwifery Services for a chart review 
as part of a research project. The purpose of this study 
will be to determine the prevalence of asymptomatic 
chlamydial infection in our pregnant clients. There are 
currently no data available in Mississippi in regard to the 
magnitude of this infection. The potential for transmission 
to the infant from the mother is well documented as well as 
the effective treatment, if diagnosed early.
No inconvenience or excess cost will be assumed by the 
client. No additional interviews will be conducted, other 
than the usual history obtained at the time of the visit.
No patient name will be utilized on any data collection 
material. The patients’ confidentiality will be maintained.




Golden TViangle Regional 
Medical Center
DATE: March 3, 1992
TO: Cynthia McAlpin, CNM
FROM: Charles A. Faulkner 
Adin in i s t r a to r
RE: Research Project
I have reviewed your request for access to and review of  the Midwifery  
Service pat ien t  charts in order to study the prevalence of asymptomatic 
chlamydial in fec t ion .  Based on the information you have provided to 
me, I see no problem witl i  this research e f f o r t .  I f  there is anything 
we can do to assist  you in the endeavor, please le t  me know.
2520 5th Street North • Columbus, MS 39701 • (601) 243-1000
APPENDIX C
MeALPIN RECORD OF DEMOGRAPHIC AND CLINICAL 
CHARACTERISTICS OF CHLAMYDIAL INFECTION
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McAlpin Record of Demographic and Clinical
Characteristics of Chlamydial Infections
Part I. Demographic Characteristics
ID
#









Part II. Clinical Characteristics
ID#
Friable
Cervix MPC^ >10 WBC^ +GC° Vaginitis Other





AUTHORIZATION FOR MEDICAL AND/OR SURGICAL TREATMENT
I hereby authorize the midwife/physician in charge of the care of
__________________________________________________  to administer any
treatment; or to administer such anesthetics; and perform such 
operations as may be deemed necessary or advisable in the 
diagnosis and on-going treatment of this patient. I authorize 
the release of any medical information necessary to process my 
insurance claims. I also request (if I am entitled to such 
benefits) payment of government benefits either to myself or to 
the party that accepts assignment on the insurance claim form. I 
hereby give my permission to the employees of Midwifery Service 
and others as authorized by them to use information contained in 
my medical record for research. Such research shall involve only 
the collection of data from the medical record for statistical 
analysis. Any reports generated as a result of such research and 
analysis shall not contain any identifying patient information. 
Patient confidentiality shall be strictly maintained.
Date  ____________________  Signed__________________________________
Patient or Person Authorized to 
Consent
Witness
If patient is unable to consent, complete the following:
Patient is unable to consent because she is a minor, ___
years of age.
Patient is unable to consent because _____  __________
*THIS AUTHORIZATION IS GOOD FOR MY LIFETIME
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
STATEMENT TO PERMIT PAYMENT OF INSURANCE BENEFITS TO PROVIDER
I request and authorize that payment of medical benefits be made 
to GTRMC/Midwifery Service for the services provided by the 
Certified Nurse Midwives in their service. I understand I am 
financially responsible for charges not covered by this 
authorization. This authorization is good for my lifetime.
Copy shall be considered as original.
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Part I. Demographic Characteristics








001 28 2 1 1 14 1 3 27 1 1
002 15 1 2 1 a 1 1 22 1 1
003 18 2 1 1 11 1 1 26 1 1
004 24 1 2 1 10 1 4 13 1 1
005 31 1 2 1 2 5 18 1 2
006 21 2 2 1 12 1 1 12 1 2
007 31 2 1 1 2 6 1 1
008 26 2 1 1 12 1 3 10 1 1
009 18 3 2 4 1 10 2 2
010 16 1 1 1 11 1 1 25 1 2
Oil 25 1 3 1 11 2 4 33 2 1
012 20 1 3 1 12 2 2 16 1 1
013 18 1 2 1 13 1 1 31 1 1
014 19 1 2 1 11 1 2 29 2 2
015 25 1 1 1 1 2 31 1 2
016 22 1 2 12 1 3 24 2 1
017 17 1 2 1 11 1 1 18 1 2
018 28 1 0 1 12 1 1 20 1 1
019 20 2 12 1 1 16 1 1
020 19 1 3 1 12 2 3 13 1 1
021 20 1 2 1 11 1 7 1 1
022 21 1 2 1 11 2 2 14 2 1
023 18 1 2 1 10 1 1 37 1 2
024 20 1 2 1 11 1 1 10 1 1
025 21 1 3 1 12 1 3 15 1 1
026 18 1 2 1 11 1 3 19 2 2




Cervix MPC'* >10 WBC^ +GC° Vaginitis Other
001 1 1 1 1 1
002 1 1 1 1
003 1 1 1 1
004 1 1 1 1 1
005 1 1 1 3
006 1 1 1 3
007 1 1 1 1
008 1 1 2 1 1
009 1 2 1 1
010 1 1 1 1 2
Oil 1 1 1 1
012 1 1 1 1
013 1 1 1 1
014 1 1 2 1 9 (2,3) 1
015 1 1 2 1 ___ 9_L4,5)
016 1 1 1 2
017 1 1 1 3
018 1 1 1 1 1
019 1 1 1 1
020 1 1 1 1
021 1 1 1 1 1
022 1 1 1 1 3
023 1 1 1 5
024 1 1 1 1 1
025 2 1 1 1
026 1 2 2 1 1
^ P C  = Mucopurulent cervicitis. ^hite blood cells. ^Gonorrhea
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027 23 1 1 1 12 1 1 20 1 1
028 19 3 1 2 3 1 1 19 1 2
029 15 2 2 1 6 1 1 13 1 1
030 22 1 2 2 12 1 2 12 1 1
031 29 1 2 1 11 3 5 14 1 1
032 18 1 2 1 12 2 1 33 2 1
033 33 1 2 1 12 2 1 31 1 2
034 20 1 2 1 12 1 1 33 1 1
035 33 1 1 12 1 2 26 1 1
036 21 1 2 1 12 3 1 23 1 2
037 21 1 2 1 12 2 3 26 1 2
038 25 2 1 13 1 3 6 1 1
039 22 1 2 12 2 2 8 1 2
040 19 1 2 1 12 1 1 10 1 2
041 18 1 2 1 13 2 1 10 1 2
042 28 1 2 1 12 2 1 9 2 2
043 22 1 2 1 11 1 4 5 1 2
044 30 1 16 1 3 22 1 1
045 22 1 1 15 1 1 19 NA NA
046 21 1 2 1 10 2 2 37 2 1
047 17 1 2 1 10 1 2 24 1 1
048 17 1 2 1 6 6 3 28 1 1
049 22 1 2 1 8 1 4 25 1 1
050 24 2 2 1 60 2 3 10 1 1
051 24 2 2 1 2 2 10 1 2
052 24 2 2 1 14 2 2 10-12 1 1




Cervix MPC^ >10 WBC^ +GC° Vaginitis Other
027 1 1 1 1
028 2 2 2 1 2 4
029 1 1 1 1
030 1 1 1 1
031 1 1 1 1 1
032 1 1 2 1 2
033 1 1 1 1 3
034 1 1 1 1
035 1 1 1 1
036 1 1 1 2
037 1 1 2 1 4
038 1 1 1 1
039 1 1 1 3 2
040 1 1 1 1 9 (3,4)
041 1 1 2 1 9 (2,4)
042 1 1 1 1 2
043 1 1 2 1 9 (2,3)
044 1 1 1 1
045 1 1 1 1
046 1 1 1 1
047 1 1 1 1
048 1 1 1 1
049 1 1 1
050 1 1 1 1
051 1 1 1 2
052 1 1 1 1 2
^ P C  = Mucopurulent cervicitis. ^hite blood cells. ^Gonorrhea,
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053 18 2 2 1 12 1 1 7 1 2
054 18 1 2 1 12 1 1 8 1 1
055 28 1 2 1 1 1 10 1 1
056 22 2 2 1 11 3 3 10 1 1
057 29 1 2 1 12 1 1 6 1 1
058 35 2 1 16 1 1 4 1 1
059 21 1 1 1 12 1 3 32 1 1
060 23 2 2 1 9 1 3 28 1 1
061 20 2 2 1 12 1 1 13 1 1
062 21 1 2 1 12 1 7 1 2
063 18 1 2 1 12 1 1 6 1 1
064 24 1 2 1 1 1 18 1 2
065 27 1 2 1 10 1 5 12 1 1
066 21 1 2 1 13 1 34 1 2
067 19 1 1 1 2 9 1 1
068 20 1 2 1 12 1 3 37 1 2
069 26 1 2 1 14 2 7 Equiv. 1
070 15 1 2 1 8 1 1 15 2 1
071 18 1 2 1 11 1 1 19 1 1
072 21 2 1 10 3 33 1 1
073 20 1 2 1 12 1 1 32 2 1
074 22 1 2 1 10 1 2 14 1 1
075 24 1 1 1 12 1 3 22 1
076 20 1 2 1 14 1 1 31 1 1
077 25 2 1 2 1 2 12 1 1
078 22 1 2 1 12 1 2 4 1 1
66
Part II. Clinical Characteristics
ID#
Friable
Cervix MPC* >10 WBC^ +GC° Vaginitis Other
053 1 1 1 1
054 1 1 1 1
055 1 1 1 1 1
056 1 1 1 1
057 1 1 1 1 1
058 1 1 1 1 1
059 1 1 1 1
060 1 1 1 1
061 1 1 1 1
062 1 1 1 1 9 (2,4)
063 1 1 1 1 1
064 2 1
065 1 1 1 1
066 1 1 2 1 9 (2,6,7)
067 1 1 1 1 2
068 1 1 1
069 1 1 1 1 2
070 1 1 1
071 1 1 1 1
072 1 1 1 1
073 1 1 1
074 1 1 1 1
075 1 1 1 1
076 1 1 1 1
077 1 1 1
078 1 1 1 1
^ P C  = Mucopurulent cervicitis. ^hite blood cells. ^Gonorrhea.
McAlpln Record of Demographic and Clinical
Characteristics of Chlamydial Infections
Part I. Demographic Characteristics
67








079 21 2 2 1 12 1 2 4 1 1
080 18 1 1 1 1 1 9 1 1
081 20 1 2 1 4 1 11 2 2









1 12 1 1 16 1 2
1 12 2 1 13 2 2
085 19 1 2 1 11 1 1 23 1 1
086 23 2 1 1 10 1 3 9 1 2
087 15 1 2 1 8 1 24 2 1
088 18 1 2 1 12 1 1 31 1 1
089 22 2 2 2 12 2 8 1 1
090 25 2 2 1 1 2 27 1 1
091 21 2 2 2 15 1 1 19 1 1
092 25 2 1 1 1 2 37 1 1
093 19 2 2 1 1 1 12 1 1
094 17 1 2 1 11 1 1 27 1 1
095 24 1 1 1 10 1 4 12 1 1
096 18 1 2 1 12 2 1 11 1 1





Part II Clinical Characteristics
ID#
Friable
Cervix MPC* >10 WBC^ +GC° Vaginitis Other
079 1 1 1 1
080 1 1 1 1
081 1 1 2
082 1 1 2 1 3
083 1 1 1 3
084 1 1 2 1 1
085 1 1 1 1 1
086 1 1 1
087 1 1 1 1
088 1 1 1 1 1
089 1 1 1 1
090 1 1 2 1 1
091 1 1 1 1
092 1 1 1 1 1
093 1 1 1 1
094 1 1 1 1 1
095 1 1 1 1
096 1 1 1 1




*MPC = Mucopurulent cervicitis. ^hite blood cells. ‘̂ Gonorrhea.
